By BullScreen Editorial Team 
Max Healthcare Institute Limited delivered a strong financial performance in its Q4 results 2026 update, supported by higher patient volumes, increased occupancy levels, and growing demand for complex medical procedures. The hospital operator continued to benefit from its strong presence in metro markets and expanding healthcare infrastructure.
The company reported gross revenue of ₹10,538 crore for FY26, up 16% from ₹9,065 crore in the previous fiscal year. Net revenue also rose 16% year-on-year to ₹10,065 crore. Profit After Tax (PAT) climbed 22% to ₹1,631 crore from ₹1,336 crore a year earlier, reflecting healthy operating growth despite cost pressures.
Operating EBITDA increased 14% to ₹2,638 crore, while the EBITDA margin slightly moderated to 26.2% from 26.8% in FY25. The decline was mainly due to higher doctor compensation costs, which pushed direct expenses to 41% of net revenue. However, indirect overheads remained stable at 32.8%, indicating cost discipline during expansion activities.
Operational metrics also showed improvement. Occupancy across the network rose to 76% from 74%, while Average Revenue Per Occupied Bed (ARPOB) reached ₹78,000, remaining among the highest in the sector. International medical tourism revenue also recorded 20% year-on-year growth.
The Q4 results 2026 also highlighted Max Healthcare’s long-term expansion strategy. The company currently operates over 6,100 beds and plans to significantly increase capacity over the next several years through brownfield and greenfield projects. Management sees potential to scale capacity to nearly 14,500 beds over the long term.
With cash reserves of ₹1,122 crore and net debt at ₹1,908 crore, Max Healthcare maintains a stable balance sheet as it prepares for future growth. Investors are likely to closely monitor execution of expansion projects and whether demand growth continues supporting earnings momentum.
Source: https://www.bseindia.com/xml-data/corpfiling/AttachHis/49477928-7f1d-4f60-a0b8-0b5f70111e4d.pdf